Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricCVSCVS HealthCICignaDGXQuest Diagnostics
Snapshot
Price$95.93$280.94$238.28
Market cap$133.62B$76.12B$23.88B
Valuation
P/E41.4x11.8x25.7x
Forward P/E59.2x9x22.3x
Growth
Revenue growth7.6%8.8%11.0%
EPS growth-46.0%30.5%14.9%
Profitability
Net margin0.7%2.3%9.1%
ROE3.9%15.2%14.1%
Balance sheet & cash
Debt / equity0.86x0.75x0.82x
Free cash flow yield9.9%9.7%5.4%
Dividend yield2.6%2.1%1.7%
Verdict
Investment ratingWeak· 32Favorable· 60Neutral· 52

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearCVStoday $96CItoday $281DGXtoday $238
2027$73.39 – $107.63+12% CAGR$274.91 – $403.20+44% CAGR$205.30 – $301.11+26% CAGR
2028$74.85 – $109.79+7% CAGR$358.67 – $526.05+37% CAGR$235.85 – $345.91+20% CAGR
2029$76.35 – $111.98+5% CAGR$467.96 – $686.34+35% CAGR$270.95 – $397.39+19% CAGR
2030$77.88 – $114.22+4% CAGR$610.54 – $895.47+34% CAGR$311.26 – $456.52+18% CAGR
2031$79.44 – $116.51+4% CAGR$796.58 – $1,168.31+33% CAGR$357.58 – $524.45+17% CAGR
5-yr CAGR-3.7% – 4.0%23.2% – 33.0%8.5% – 17.1%